Table: Zeria Pharm -2025/26 parent results
May 8 (Reuters)-
Zeria Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2026 Mar 31, 2025 Mar 31, 2027 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 35.62 34.71
(+2.6 pct) (+2.0 pct)
Operating 444 mln 1.27
(-65.0 pct) (+7.9 pct)
Recurring 3.25 3.42
(-5.1 pct) (+27.4 pct)
Net 2.97 2.86
(+4.0 pct) (+74.7 pct)
EPS 67.46 yen 64.86 yen
Ann Div 49.00 yen 47.00 yen 50.00 yen
-Q2 Div 24.00 yen 23.00 yen 25.00 yen
-Q4 Div 25.00 yen 24.00 yen 25.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T